CVS Health Corporation CVS posted adjusted earnings per share (EPS) of $1.19 in the fourth quarter of 2024, down 43.9% year ...

The next Diablo 4 expansion won’t be out in 2025, in spite of the studio’s previous comments about releasing them annually.

Blizzard has announced that Diablo 4 's second expansion after Vessel of Hatred will launch sometime in 2026. As reported by ...

This announcement may come as a surprise to many Diablo 4 fans, who have speculated whether the rumored multiple expansions ...

The dividend is payable on March 11, 2025, to stockholders of record as of February 24, 2025.Maximize Your Portfolio with Data Driven ...

If you were hoping for a new Diablo 4 expansion in 2025, you're unfortunately going to be waiting just a bit longer.

As per Intent Market Research, the Cell Analysis Market was valued at USD 19.2 billion in 2023-e and will surpass USD 38.4 billion by 2030; growing at a CAGR of 10.4% during 2024 - 2030.

The Biosensors Market is growing with demand for rapid, accurate diagnostics in healthcare, food safety, and environmental monitoring, driven by advances in biotechnology.Austin, Feb. 12, 2025 (GLOBE ...

The Biomarkers Market is expected to grow from USD 79.3 billion in 2023-e to USD 187.4 billion by 2030, at a CAGR of 14.7% ...

The top opportunities in the genomic data analysis and interpretation market segmented by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $756.71 million ...